Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
09/2014
09/02/2014US8822487 Opioid agonist/opioid antagonist/acetaminophen combinations
09/02/2014US8822474 6,7-dihydrothieno[3,2-d]pyrimidine for the treatment of inflammatory diseases
09/02/2014US8822454 Bisfluoroalkyl-1,4-benzodiazepinone compounds
09/02/2014US8822450 1,6-diazabicyclo [3,2,1] octan-7-one derivatives and their use in the treatment of bacterial infections
09/02/2014US8822422 Antitumor agent
09/02/2014US8822421 E2F as a target of hormone refractory prostate cancer
09/02/2014US8822418 Treatment of muscular dystrophies and related disorders
09/02/2014US8822414 Heterocyclic compounds suitable for the treatment of dyslipidemia
09/02/2014US8822169 HMG1 antibody for treating inflammatory conditions
09/02/2014US8821936 Solid pharmaceutical formulation
09/02/2014US8821929 Tamper resistant dosage forms
09/02/2014US8821923 Using bucky paper as a therapeutic aid in medical applications
09/02/2014US8821906 Biocompatible polymer
09/02/2014US8821904 Topical composition and use thereof for the prophylaxis and the treatment of defects connected to inflammatory dermopathies
09/02/2014US8821892 Yeast-based therapeutic for chronic hepatitis C infection
09/02/2014US8821881 Quil A fraction with low toxicity and use thereof
09/02/2014US8821867 4-1BB binding molecules
09/02/2014US8821866 Methods of treating and preventing colitis involving IL-13 and NK-T cells
09/02/2014US8821858 Lyophilized platelet rich plasma for the use in wound healing (chronic or acute) and bone or tissue grafts or repair
08/2014
08/28/2014WO2014130922A1 Compositions and methods for treating fungal infections
08/28/2014WO2014130016A1 Drug combinations to treat liver cancer
08/28/2014WO2014128487A1 Treatment of cancer
08/28/2014WO2014128235A1 Methods of treating cancer and preventing drug resistance
08/28/2014WO2014128127A1 Methods and pharmaceutical compositions for treatment of prostate cancer
08/28/2014US20140243415 Compounds inhibiting galectin-1 expression, cancer cell proliferation, invasion, and tumorigenesis
08/28/2014US20140243408 Use of aminoacetonitrile derivatives against endoparasites
08/28/2014US20140243405 A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (cbdv) and cannabidiol (cbd)
08/28/2014US20140243400 Compositions comprising citric acid and malic acid and methods and uses thereof
08/28/2014US20140243396 Method of treating mucoepidermoid carcinoma
08/28/2014US20140243380 Combination therapy with nitrated lipids and inhibitors of the renin-angiotensin-aldosterone system
08/28/2014US20140243379 Adhesive mixture for transdermal delivery of highly plasticizing drugs
08/28/2014US20140243361 Polymorphs of arry-380, a selective herb2 inhibitor and pharmaceutical compositions contianing them
08/28/2014US20140243353 5- or 6-substituted 3-hydroxy-2(1h)-pyridinones as d-amino acid oxidase (daao) inhibitors in therapy of diseases such as schizophrenia, cognitive disorder and paid
08/28/2014US20140243350 Use of serotonin receptor agonists for treatment of movement disorders
08/28/2014US20140243347 SUBSTITUTED 3,4-DIHYDROPYRROLO[1,2-a]PYRAZIN-1(2H)-ONE DERIVATIVES AS KINASES INHIBITORS
08/28/2014US20140243341 Broad-spectrum antivirals against 3c or 3c-like proteases of picornavirus-like supercluster: picornaviruses, caliciviruses and coronaviruses
08/28/2014US20140243340 Cytochrome p450 oxidase inhibitors and uses thereof
08/28/2014US20140243328 Imidazopyridine derivatives, process for preparation thereof and therapeutic use thereof
08/28/2014US20140243327 Riminophenazines with 2-(heteroaryl) amino substituents and their anti-microbial activity
08/28/2014US20140243311 Novel octahydrothienoquinoline derivative, pharmaceutical composition comprising derivative, and use of these
08/28/2014US20140243303 Spirocyclic molecules as protein kinase inhibitors
08/28/2014US20140243302 Bridged bicyclic compounds for the treatment of bacterial infections
08/28/2014US20140243295 Use of substituted 2,3-dihydroimidazo[1,2-c]quinazolines
08/28/2014US20140243289 Prodrugs of modulators of abc transporters
08/28/2014US20140243276 Smac mimetic (birinapant) for use in the treatment of proliferative diseases (cancer)
08/28/2014US20140243273 Methods for treating inflammatory diseases and pharmaceutical combinations useful therefor
08/28/2014US20140243270 Pharmaceutical composition containing neuregulin isoforms
08/28/2014US20140243269 Method of effecting neuroprotection using soluble neuregulin isoforms
08/28/2014US20140243262 Pharmaceutical formulations containing an sglt2 inhibitor
08/28/2014US20140243260 Chimeric fibroblast growth factor 23 proteins and methods of use
08/28/2014US20140242691 Neural Progenitor Cell Populations
08/28/2014US20140242200 Water-soluble extracts of artemisia dracunculus (tarragon) for improvement of glucose metabolism
08/28/2014US20140242190 Use of deoxyelephantopin (det) and analogues thereof for treatment of melanoma
08/28/2014US20140242178 Taste-masked formulations of raltegravir
08/28/2014US20140242157 Epicatechin compositions and methods
08/28/2014US20140242150 Therapeutic compositions and methods of treatment with capsianoside-type compounds
08/28/2014US20140242125 Muscle tissue regeneration using muscle fiber fragments
08/28/2014US20140242124 Agonists of Guanylate Cyclase and Their Uses
08/28/2014US20140242119 Amino alcohol derivatives for the treatment of demyelinating peripheral neuropathies
08/28/2014US20140242099 Compounds for inflammation and immune-related uses
08/28/2014US20140242096 Compositions and methods related to graft versus host disease and treatments thereof
08/28/2014US20140242094 Methods related to tim 3, a th1-specific cell surface molecule, for activating antigen presenting cells
08/28/2014US20140242088 Hsp90 inhibitor combinations
08/28/2014US20140242086 Polynucleotides encoding signal peptide-containing molecules
08/28/2014US20140242082 Combination therapy for the treatment of ocular neovascular disorders
08/28/2014US20140242063 Pharmaceutical compositions
08/28/2014US20140242061 Compositions and methods for treating gaucher disease
08/28/2014US20140242054 Methods and compositions for treating respiratory conditions using platelet enriched plasma
08/28/2014US20140242051 Probiotic, Lactic Acid-Producing Bacteria and Uses Thereof
08/28/2014US20140242035 Methods and systems for treating cell proliferation disorders
08/28/2014US20140242028 Antiviral compounds
08/28/2014US20140242027 Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
08/28/2014US20140242010 Method And Compositions For Treating Skin
08/28/2014US20140242007 Topical preparation containing ngf for inducing skin pigmentation and for the treatment of cutaneous dyschromias and vitiligo
08/28/2014US20140241983 Methods and Compositions for Enhancing the Therapeutic Effect of Anti-Tumor T Cells
08/28/2014US20140238412 Methods for treating obstructive sleep apnea
08/27/2014EP2769737A1 Combination of an anti-CTLA4 antibody with etoposide for the synergistic treatment of proliferative diseases
08/27/2014EP2769713A1 Solid oral composition comprising a S1P receptor agonist and a sugar alcohol
08/27/2014EP2768536A2 Method for treating type i and type ii diabetes
08/27/2014EP2768503A1 Pharmaceutical compositions comprising beta-lactam antibiotic, sulbactam and beta-lactamase inhibitor
08/26/2014US8816091 Crystalline forms of an 8-azabicyclo[3.2.1]octane compound
08/26/2014US8815948 High volume and alternative methods of delivering homeopathic remedies
08/26/2014US8815946 Inhibition of proliferation and fibrotic response of activated corneal stromal cells
08/26/2014US8815945 Use of bis [thiohydrazide amide] compounds such as elesclomol for treating cancers
08/26/2014US8815926 Substituted pyrrolo[3,4-D]imidazoles for the treatment of MDM2/4 mediated diseases
08/26/2014US8815925 Use of combination preparations comprising antifungal agents
08/26/2014US8815890 Rhinitis treatment regimens
08/26/2014US8815889 Compositions and methods for increasing insulin sensitivity
08/26/2014US8815864 Indanyloxydihydrobenzofuranylacetic acids
08/26/2014US8815805 Formulations having an antagonist of α5β1 for anti-angiogenesis and cancer treatment
08/26/2014US8815803 Method for increasing body height comprising systemic administration of CNP-53
08/26/2014US8815801 Controlled release composition and method of producing the same
08/26/2014US8815289 Tamper resistant dosage forms
08/26/2014US8815287 Opiod agonist formulations with releasable and sequestered antagonist
08/26/2014US8815286 Pharmaceutical composition for treating hypertension and metabolic syndrome and use thereof
08/26/2014US8815277 In situ forming hydrogel and biomedical use thereof
08/26/2014US8815271 Pesticidal compositions and processes related thereto
08/26/2014US8815255 Use of Mycoplasma bovis antigen
08/26/2014US8815241 Use of combination of anti-angiogenic substance and c-kit kinase inhibitor
08/26/2014US8814926 Methods and apparatus for stenting comprising enhanced embolic protection coupled with improved protections against restenosis and thrombus formation
1 ... 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 ... 1151